By 2024, Mounjaro generated $11.54 billion in annual sales, while Zepbound contributed $4.93 billion figures that have helped push the company into territory once only reached by the biggest tech giants
While long-term data is still emerging, early research suggests they may help manage weight gain, improve metabolic health, and even ease menopause symptoms like hot flashes and poor sleep
Current evidence suggests stopping GLP-1 therapy before conception is the safest approach, though individual circumstances vary based on your health profile and metabolic genetics
"People have a number of (gastrointestinal) complaints on these drugs, and that's expected," Imaeda said
Convenience: Open seven days a week with same-day appointments available, making it easy for patients to get started quickly